Randomized Controlled Trial of Laparoscopic versus Open Radical Cystectomy in a Laparoscopic Naïve Center
Table 1
Baseline patient characteristics.
Whole cohort N = 60
LRC N = 30
ORC N = 30
value
Age (years)
59.02 ± 7.55
57.20 ± 8.38
60.83 ± 6.24
0.062
Follow-up (months)
20.5 (16–24)
20.4 (16–24)
20.7 (17–24)
0.6
Sex
Male
47 (78.3%)
22 (73.3%)
25 (83.3%)
0.532
Female
13 (21.7%)
8 (26.7%)
5 (16.7)
ASA
1
22 (36.7%)
12 (40%)
10 (33.3%)
0.838
2
35 (58.3%)
17 (56.7%)
18 (60%)
3
3 (5%)
1 (3.3%)
2 (6.7%)
Body mass index (BMI)
24.9 ± 2 (range: 20–28.5)
24.9 ± 1.8 (range: 20.5–28)
24.8 ± 2.1 (range: 20–28.5)
0.8
Previous abdominal surgery
8 (13.3%)
4 (13.3%)
4 (13.3%)
1.00
Neoadjuvant chemotherapy
22 (36.7%)
14 (46.7%)
8 (26.7%)
0.18
SCr preoperative (mg/dl)
1.12 ± 0.30
1.08 ± 0.25
1.15 ± 0.34
0.323
SCr 1st postoperative day (mg/dl)
1.08 ± 0.19
1.03 ± 0.15
1.14 ± 0.20
0.026
Hb preoperative (gm/dl)
12.00 ± 1.50
12.01 ± 1.46
11.98 ± 1.57
0.932
Hb 1st postoperative day (gm/dl)
10.62 ± 1.25
10.70 ± 1.24
10.53 ± 1.29
0.611
Clinical T stage
cT1
10 (16.7%)
5 (16.7%)
5 (16.7%)
0.920
cT2
34 (56.7%)
18 (60%)
16 (53.3%)
cT3
16 (26.7%)
7 (23.3%)
9 (30%)
Clinical N stage
cN0
49 (81.7%)
23 (76.7%)
26 (86.7%)
0.488
cN1-3
11 (18.3%)
7 (23.3%)
4 (13.3%)
Diversion
Orthotopic
9 (15%)
4 (13.3%)
5 (16.7%)
0.99
Ileal conduit
51 (85%)
26 (86.7%)
25 (83.3%)
LRC: laparoscopic radical cystectomy; ORC: open radical cystectomy; ASA: American Society of Anesthesiologists’ classification; SCr: serum creatinine; Hb: hemoglobin. value ≤0.05 is considered significant. Values are given in means ± SD or n (%).
